In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Wind Energy Research and Development 
Act of 2009''.

SEC. 2. WIND ENERGY RESEARCH AND DEVELOPMENT PROGRAM.

    (a) In General.--The Secretary of Energy shall carry out a program 
of research and development to--
            (1) improve the energy efficiency, reliability, and 
        capacity of wind turbines;
            (2) optimize the design and adaptability of wind energy 
        systems to the broadest practical range of atmospheric 
        conditions; and
            (3) reduce the cost of construction, generation, and 
        maintenance of wind energy systems.
    (b) Program.--The program under this section shall focus on 
research and development of--
            (1) new materials and designs to make larger, lighter, less 
        expensive, and more reliable rotor blades;
            (2) technologies to improve gearbox performance and 
        reliability;
            (3) automation, materials, and assembly of large-scale 
        components to reduce manufacturing costs;
            (4) low-cost transportable towers greater than 100 meters 
        in height to capitalize on improved wind conditions at higher 
        elevations;
            (5) advanced computational modeling tools to improve--
                    (A) the reliability of aeroelastic simulations of 
                wind energy systems;
                    (B) understanding of the interaction between each 
                wind turbine component;
                    (C) siting of wind energy systems to maximize 
                efficiency and minimize variable generation;
                    (D) integration of wind energy systems into the 
                existing electric grid to ensure reliability; and
                    (E) understanding of the wake effect between upwind 
                and downwind turbine operations;
            (6) advanced control systems and blade sensors to improve 
        performance and reliability under a wide variety of wind 
        conditions;
            (7) advanced generators, including--
                    (A) medium-speed and low-speed generators;
                    (B) direct-drive technology; and
                    (C) the use of advanced magnets in generator 
                rotors;
            (8) wind technology for offshore applications;
            (9) methods to assess and mitigate the effects of wind 
        energy systems on radar and electromagnetic fields;
            (10) wind turbines with a maximum electric power production 
        capacity of 100 kilowatts or less;
            (11) technical processes to enable--
                    (A) scalability of transmission from remotely 
                located renewable resource rich areas; and
                    (B) optimization of advanced infrastructure design, 
                including high voltage transmission; and
            (12) other research areas as determined by the Secretary.

SEC. 3. WIND ENERGY DEMONSTRATION PROGRAM.

    (a) In General.--The Secretary of Energy shall conduct a wind 
energy demonstration program. In carrying out this section, the 
Secretary shall ensure that--
            (1) the program is of sufficient size and geographic 
        diversity to measure wind energy system performance under the 
        full productive range of wind conditions in the United States;
            (2) demonstration projects carried out under this program 
        are--
                    (A) conducted in collaboration with industry and, 
                as appropriate, with academic institutions; and
                    (B) located in various geographic areas 
                representing various wind class regimes; and
            (3) data collected from demonstration projects carried out 
        under this program is useful for carrying out section 2(b).
    (b) Cost-Sharing.--The Secretary shall carry out the program under 
this section in compliance with section 988(a) through (d) and section 
989 of the Energy Policy Act of 2005 (42 U.S.C. 16352(a) through (d) 
and 16353).

SEC. 4. EQUAL OPPORTUNITY.

    In carrying out this Act, the Secretary of Energy shall--
            (1) coordinate with the Office of Minority Economic Impact 
        and with the Office of Small and Disadvantaged Business 
        Utilization; and
            (2) provide special consideration to applications submitted 
        by institutions, businesses, or entities containing majority 
        representation by individuals identified in section 33 or 34 of 
        the Science and Engineering Equal Opportunities Act (42 U.S.C. 
        1885a or 1885b).

SEC. 5. COMPETITIVE AWARDS.

    Awards under section 2 and section 3 shall be made on a competitive 
basis with an emphasis on technical merit.

SEC. 6. COORDINATION AND NONDUPLICATION.

    To the maximum extent practicable the Secretary of Energy shall 
coordinate activities under this Act with other programs of the 
Department of Energy and other Federal research programs.

SEC. 7. AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated to the Secretary of Energy 
to carry out this Act $200,000,000 for each of the fiscal years 2010 
through 2014.

            Passed the House of Representatives September 9, 2009.

            Attest:

                                            LORRAINE C. MILLER,

                                                                 Clerk.
Example Output: Wind Energy Research and Development Act of 2009 - Directs the Secretary of Energy to carry out a research and development program to: (1) improve the energy efficiency, reliability, and capacity of wind turbines; (2) optimize the design and adaptability of wind energy systems to the broadest practical range of atmospheric conditions; and (3) reduce the cost of construction, generation, and maintenance of such systems.





Directs the Secretary to conduct a wind energy demonstration program to measure wind energy system performance under the full productive range of wind conditions in the United States.

Requires awards under such programs to be made on a competitive basis with an emphasis on technical merit.

Requires the Secretary, in carrying out this Act, to: (1) coordinate with the Office of Minority Economic Impact and with the Office of Small and Disadvantaged Business Utilization; and (2) provide special consideration to applications submitted by institutions, businesses, or entities containing majority representation of women, minorities, or persons with disabilities in science and engineering.

Authorizes appropriations.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Helping Effective Antibiotics Last 
Act of 2015'' or the ``HEAL Act''.

SEC. 2. APPROVAL OF CERTAIN DRUGS FOR USE IN A WELL-DEFINED POPULATION 
              OF PATIENTS.

    (a) Approval of Certain Antibacterial.--Section 505 of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended by adding at 
the end the following:
    ``(x) Approval of Certain Antibacterial Drugs for Use in a Well-
Defined Population of Patients.--
            ``(1) Unmet medical need defined.--In this subsection, the 
        term `unmet medical need' means that the antibacterial drug 
        involved--
                    ``(A) has improved efficacy, as demonstrated in 
                adequate, well-controlled studies in humans, for 
                specific diseases or conditions, where current 
                therapies have been shown to be less effective;
                    ``(B) has clinically meaningful decreased harms, 
                demonstrated in adequate, well-controlled studies in 
                humans, for diseases or conditions, where current 
                therapies have unacceptable adverse effects; or
                    ``(C) has improved convenience, as demonstrated in 
                adequate, well-controlled studies in humans, where 
                improved convenience results in improved effectiveness 
                or decreased harms.
            ``(2) Approval.--Upon receipt of an application under 
        subsection (b) for an antibacterial drug that is intended to 
        treat a serious or life-threatening disease or condition, 
        irrespective of whether the drug is intended to address an 
        unmet medical need, the Secretary--
                    ``(A) may approve the drug under subsection (c) 
                only for treating a well-defined population of 
                patients, and based upon the results of clinical trials 
                inclusive of human subjects representative of such 
                well-defined population;
                    ``(B) in determining whether to grant such 
                approval, shall rely on superior outcomes over 
                available therapies based on direct measures of patient 
                benefits, as demonstrated in adequate, well-controlled 
                studies in the well-defined patient population, such 
                as--
                            ``(i) decreased mortality;
                            ``(ii) irreversible morbidity; or
                            ``(iii) validated surrogate endpoints that 
                        reflect mortality or irreversible morbidity; 
                        and
                    ``(C) shall require the labeling of drugs approved 
                pursuant to this subsection to prominently include in 
                the prescribing information required by section 201.57 
                of title 21, Code of Federal Regulations (or any 
                successor regulation)--
                            ``(i) the population of patients with 
                        respect to which the added benefit over 
                        available therapies is expected as studied in 
                        adequate, well-controlled studies that form the 
                        basis for approval; and
                            ``(ii) the method for identifying members 
                        of that population.
            ``(3) Risk evaluation and mitigation strategy.--The 
        Secretary--
                    ``(A) shall require a risk evaluation and 
                mitigation strategy (REMS) under section 505-1 for each 
                drug approved under this subsection; and
                    ``(B) may include in any such strategy additional 
                elements to assure the safe use of the drug under 
                subsections (e) and (f) of section 505-1.
            ``(4) Rule of construction.--Nothing in this subsection 
        shall be construed to alter the standards of evidence under 
        subsection (c) or (d) (including the substantial evidence 
        standard in subsection (d)). Subsections (c) and (d) and such 
        standards of evidence apply to the review and approval of drugs 
        under this subsection, including whether a drug is safe and 
        effective. Nothing in this subsection shall be construed to 
        limit the authority of the Secretary to approve products 
        pursuant to this Act and the Public Health Service Act as 
        authorized prior to the date of enactment of this subsection.
            ``(5) Effective immediately.--The Secretary shall have the 
        authorities vested in the Secretary by this subsection 
        beginning on the date of enactment of this subsection, 
        irrespective of when and whether the Secretary promulgates 
        final regulations to carry out this subsection.''.
    (b) Licensure of Certain Biological Products.--Section 351(j) of 
the Public Health Service Act (42 U.S.C. 262(j)) is amended--
            (1) by striking ``(j)'' and inserting ``(j)(1)'';
            (2) by inserting ``505(x),'' after ``505(p),''; and
            (3) by adding at the end the following:
    ``(2) In applying section 505(x) of the Federal Food, Drug, and 
Cosmetic Act to the licensure of biological products under this 
section--
            ``(A) references to an antibacterial drug with added 
        benefits over available therapies for a well-defined population 
        that is intended to treat a serious or life-threatening disease 
        or condition shall be construed to refer to biological products 
        with added benefits over available therapies for a well-defined 
        population intended to treat a bacterial infection associated 
        with a serious or life-threatening disease; and
            ``(B) references to an application submitted under section 
        505(b) of such Act and to approval of a drug under section 
        505(c) of such Act shall be construed to refer to an 
        application submitted under subsection (a) of this section and 
        to licensure of a biological product under such subsection (a), 
        respectively.''.
    (c) Monitoring.--Title III of the Public Health Service Act is 
amended by inserting after section 317T (42 U.S.C. 247b-22) the 
following:

``SEC. 317U. MONITORING OF ANTIBACTERIAL DRUG USE, PATIENT OUTCOMES, 
              AND RESISTANCE.

    ``(a) Monitoring.--The Secretary, acting through the Director of 
the Centers for Disease Control and Prevention, shall use the National 
Healthcare Safety Network or another appropriate monitoring system to 
monitor--
            ``(1) changes in patient outcomes such as mortality and 
        irreversible morbidity causally related to antibacterial 
        resistance; and
            ``(2) changes in bacterial resistance to drugs in relation 
        to patient outcomes.
    ``(b) Public Availability of Data.--The Secretary, acting through 
the Director of the Centers for Disease Control and Prevention, shall 
make the data derived from monitoring under this section publicly 
available for the purposes of--
            ``(1) improving the monitoring of important trends in 
        patient outcomes in relation to antibacterial resistance; and
            ``(2) ensuring appropriate stewardship of antibacterial 
        drugs, including those receiving approval or licensure for a 
        well-defined population pursuant to section 505(x) of the 
        Federal Food, Drug, and Cosmetic Act.''.

SEC. 3. SUSCEPTIBILITY TEST INTERPRETIVE CRITERIA FOR MICROBIAL 
              ORGANISMS.

    (a) In General.--Section 511 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 360a) is amended to read as follows:

``SEC. 511. SUSCEPTIBILITY TEST INTERPRETIVE CRITERIA FOR MICROBIAL 
              ORGANISMS.

    ``(a) In General.--The Secretary shall--
            ``(1) identify upon approval or licensing of antibacterial 
        drugs (including biological products intended to treat a 
        bacterial infection and other types of antimicrobial drugs, as 
        deemed appropriate by the Secretary), including qualified 
        infectious disease products, susceptibility test interpretive 
        criteria for such drugs based upon patient outcomes of 
        mortality and morbidity from adequate and well-controlled 
        studies and such other confirmatory evidence as the Secretary 
        deems necessary; and
            ``(2) update, consistent with subsection (b), such criteria 
        as needed based upon scientific evidence of changes in patient 
        outcomes.
    ``(b) Responding to Changes in Patient Outcomes To Evaluate 
Susceptibility Test Interpretive Criteria.--
            ``(1) In general.--As needed based on evidence related to 
        changes in patient outcomes, the Secretary shall--
                    ``(A) evaluate any new scientific studies on 
                changes in patient outcomes in relation to 
                susceptibility test interpretive criteria; and
                    ``(B) publish on the public Website of the Food and 
                Drug Administration a notice--
                            ``(i) presenting suggested new or updated 
                        interpretive criteria; and
                            ``(ii) if needed, hold a public advisory 
                        committee to discuss scientific evidence 
                        related to changes in interpretative criteria.
            ``(2) Annual compilation of notices.--Each year, the 
        Secretary shall compile the notices published under paragraph 
        (1)(B) noting any changes from prior notices and publish such 
        compilation in the Federal Register.
    ``(c) Definition.--In this section, the term `susceptibility test 
interpretive criteria' means one or more specific values which 
characterize patient outcomes in relation to the degree to which 
bacteria or other microbes are more resistant to treatment as measured 
by patient outcomes.''.
    (b) Conforming Amendment.--Section 1111 of the Food and Drug 
Administration Amendments Act of 2007 (42 U.S.C. 247d-5a; relating to 
identification of clinically susceptible concentrations of 
antimicrobials) is repealed.
    (c) Report to Congress.--Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human Services shall 
submit to the Committee on Energy and Commerce of the House of 
Representatives and the Committee on Health, Education, Labor, and 
Pensions of the Senate a report on the progress made in implementing 
section 511 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
360a), as amended by this section.

SEC. 4. REQUIRING DEMONSTRATION OF SUPERIOR OUTCOMES FOR QUALIFIED 
              INFECTIOUS DISEASE PRODUCTS TO RECEIVE AN EXTENDED 
              EXCLUSIVITY PERIOD.

    Section 505E(g) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 355f(g)) is amended by striking ``means an antibacterial or 
antifungal drug for human use intended to treat'' and inserting ``means 
an antibacterial or antifungal drug for human use that is demonstrated 
to produce superior outcomes over available therapies, based on direct 
measures of patient benefits in clinical trials, and that is intended 
to treat''.

SEC. 5. GUIDANCE ON TARGET PRODUCT PROFILES.

    Not later than 18 months after the date of enactment of this Act, 
the Commissioner of Food and Drugs, in consultation with the 
Administrator of the Centers for Medicare & Medicaid Services, the 
Director of the Indian Health Service, the Secretary of Defense, and 
the Secretary of Veterans Affairs, shall issue guidance on the 
development of target product profiles for novel antibacterial drugs 
focused on public health priorities.
Example Output: Helping Effective Antibiotics Last Act of 2015 or the HEAL Act This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to approve an antibacterial drug or biological product that is intended to treat a serious or life-threatening condition only for treating a well-defined population of patients. To be approved, the antibacterial product must produce superior outcomes over available therapies in the well-defined patient population. A product approved by this pathway must include in its prescribing information the population of patients expected to benefit from using the product and the method for identifying members of that population. The FDA must require each product to have a risk evaluation and mitigation strategy. The Centers for Disease Control and Prevention must monitor changes to bacterial drug resistance and changes to patient outcomes caused by bacterial drug resistance. Upon approval of antibacterial products, the FDA must identify susceptibility test interpretive criteria (the drug concentrations where a type of bacteria is categorized as susceptible, intermediate, or resistant) and update the criteria as needed based upon evidence of changes in patient outcomes.  To be eligible for an exclusivity period extension, a qualified infectious disease product must be demonstrated to produce superior outcomes over available therapies. The FDA must issue guidance on the development of target product profiles for antibacterial drugs.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Net Price Calculator Improvement 
Act''.

SEC. 2. MINIMUM STANDARDS FOR NET PRICE CALCULATORS.

    Section 132(h) of the Higher Education Act of 1965 (20 U.S.C. 
1015a(h)) is amended--
            (1) by redesignating paragraph (4) as paragraph (6);
            (2) in paragraph (2), by inserting before the period ``, 
        and, not later than 1 year after the date of enactment of the 
        Net Price Calculator Improvement Act, shall meet the 
        requirements of paragraph (4)(B)'';
            (3) in paragraph (3), by inserting after the first sentence 
        the following: ``Not later than 1 year after the date of 
        enactment of the Net Price Calculator Improvement Act, such 
        calculator shall meet the requirements of paragraph (4).''; and
            (4) by inserting after paragraph (3) the following:
            ``(4) Minimum requirements for net price calculators.--Not 
        later than 1 year after the date of enactment of the Net Price 
        Calculator Improvement Act, a net price calculator for an 
        institution of higher education shall, at a minimum, meet the 
        following requirements:
                    ``(A) The link for the calculator--
                            ``(i) is clearly labeled as a `net price 
                        calculator' and prominently, clearly, and 
                        conspicuously (in such size and contrast (such 
                        as shade) that it is readily noticeable and 
                        readable) posted in locations on the 
                        institution's website where information on 
                        costs and aid is provided (such as financial 
                        aid, prospective students, or tuition and fees 
                        web pages);
                            ``(ii) matches in size and font to the 
                        other prominent links on the primary menu; and
                            ``(iii) may also be included on the 
                        institution's compliance web page, which 
                        contains information relating to compliance 
                        with Federal, State, and local laws.
                    ``(B) The results screen for the calculator 
                specifies the following information:
                            ``(i) The individual net price (as 
                        calculated under paragraph (2)) for the 
                        individual student, which is the most visually 
                        prominent figure on the results screen.
                            ``(ii) Cost of attendance, including--
                                    ``(I) tuition and fees;
                                    ``(II) average annual cost of room 
                                and board for the institution for a 
                                first-time, full-time undergraduate 
                                student enrolled in the institution;
                                    ``(III) average annual cost of 
                                books and supplies for a first-time, 
                                full-time undergraduate student 
                                enrolled in the institution; and
                                    ``(IV) estimated cost of other 
                                expenses (including personal expenses 
                                and transportation) for a first-time, 
                                full-time undergraduate student 
                                enrolled in the institution.
                            ``(iii) Estimated total need-based grant 
                        aid and merit-based grant aid, from Federal, 
                        State, and institutional sources, that may be 
                        available to the individual student, showing 
                        the subtotal for each category and the total of 
                        all sources of grant aid.
                            ``(iv) Percentage of the first-time, full-
                        time undergraduate students enrolled in the 
                        institution that received any type of grant aid 
                        described in clause (iii).
                            ``(v) The disclaimer described in paragraph 
                        (6).
                            ``(vi) In the case of a calculator that--
                                    ``(I) includes questions to 
                                estimate a student's (or prospective 
                                student's) eligibility for veterans' 
                                education benefits (as defined in 
                                section 480) or educational benefits 
                                for active duty service members, such 
                                benefits are displayed on the results 
                                screen in a manner that clearly 
                                distinguishes them from the grant aid 
                                described in clause (iii); or
                                    ``(II) does not include questions 
                                to estimate eligibility for the 
                                benefits described in subclause (I), 
                                the results screen indicates that 
                                certain students (or prospective 
                                students) may qualify for such benefits 
                                and includes a link to information 
                                about such benefits.
                    ``(C) The institution populates the calculator with 
                data from not earlier than 2 academic years prior to 
                the most recent academic year.
            ``(5) Prohibition on use of data collected by the net price 
        calculator.--A net price calculator for an institution of 
        higher education shall--
                    ``(A) clearly indicate which questions are required 
                to be completed for an estimate of the net price from 
                the calculator;
                    ``(B) in the case of a calculator that requests 
                contact information from users, clearly mark such 
                requests as `optional';
                    ``(C) prohibit any personally identifiable 
                information provided by users from being sold or made 
                available to third parties; and
                    ``(D) clearly state `Any information that you 
                provide on this site is confidential. The Net Price 
                Calculator does not store your responses or require 
                personal identifying information of any kind.'.''.

SEC. 3. UNIVERSAL NET PRICE CALCULATOR.

    Section 132(h) of the Higher Education Act of 1965 (20 U.S.C. 
1015a(h)), as amended by section 2, is further amended by adding at the 
end the following:
            ``(7) Universal net price calculator.--
                    ``(A) In general.--The Secretary may develop a 
                universal net price calculator that--
                            ``(i) enables users to answer one set of 
                        questions and receive net prices for any 
                        institution that is required to have a net 
                        price calculator under this subsection;
                            ``(ii) provides the information required 
                        under subparagraphs (B) and (C) of paragraph 
                        (4) for each institution for which a net price 
                        is being sought;
                            ``(iii) is developed in consultation with 
                        the heads of relevant Federal agencies; and
                            ``(iv) before being finalized and publicly 
                        released, is tested in accordance with 
                        subparagraph (B).
                    ``(B) Consumer testing.--
                            ``(i) In general.--If the Secretary 
                        develops a universal net price calculator under 
                        subparagraph (A), the Secretary, in 
                        consultation with the heads of relevant Federal 
                        agencies, shall establish a process to submit 
                        the universal net price calculator developed 
                        under this paragraph for consumer testing among 
                        representatives of students (including low-
                        income students, first generation college 
                        students, adult students, and prospective 
                        students), students' families (including low-
                        income families, families with first generation 
                        college students, and families with prospective 
                        students), institutions of higher education, 
                        secondary school and postsecondary counselors, 
                        and nonprofit consumer groups.
                            ``(ii) Length of consumer testing.--The 
                        Secretary shall ensure that the consumer 
                        testing lasts no longer than 6 months after the 
                        process for consumer testing is developed under 
                        clause (i).
                            ``(iii) Use of results.--The results of 
                        consumer testing under clause (i) shall be used 
                        in the final development of the universal net 
                        price calculator.
                            ``(iv) Reporting requirement.--Not later 
                        than 3 months after the date the consumer 
                        testing under clause (i) concludes, the 
                        Secretary shall submit to Congress the final 
                        universal net price calculator and a report 
                        detailing the results of such testing, 
                        including whether the Secretary added any 
                        additional items to the calculator as a result 
                        of such testing.
                            ``(v) Authority to modify.--The Secretary 
                        may modify the definitions, terms, formatting, 
                        and design of the universal net price 
                        calculator based on the results of consumer 
                        testing required under this paragraph and 
                        before finalizing the calculator.
            ``(8) Report from secretary.--Not later than 1 year after 
        the date of enactment of the Net Price Calculator Improvement 
        Act, the Secretary shall submit a report to Congress on steps 
        taken to raise awareness of net price calculators among 
        prospective students and families, particularly among students 
        in middle school and high school and students from low-income 
        families.''.
Example Output:
Net Price Calculator Improvement Act - Amends the Higher Education Act of 1965 to establish the minimum requirements for the net price calculator that each institution of higher education (IHE) receiving federal funds under title IV (Student Assistance) of the Act must include on its website. (An IHE's "net price" is the average yearly price actually charged to first-time, full-time undergraduate students receiving student aid at the school after deducting such aid.) Requires the link for the calculator to be clearly labeled and conspicuously posted on an IHE's website. Requires each calculator's results page to include:  the individual net price of attending the IHE (the individual net price is calculated like the net price but takes into account the cost of attendance for, and aid available to, the individual student to the extent practicable); the cost of attending the IHE; the estimated total need- and merit-based grant aid from federal, state, and institutional sources that may be available to the individual student; the percentage of such students enrolled at the school who receive any of that grant aid; and a notice that an estimate of an individual's net price is non-binding and subject to change.  Requires calculators that estimate a user's eligibility for veterans' education benefits or educational benefits for active duty service members to clearly distinguish those benefits from other grant-aid. Requires calculators that do not make such estimates to provide users with notice of, and a link to information concerning, those benefits. Directs IHEs to populate their calculators with data from not earlier than two academic years prior to the most recent academic year. Requires the calculators to: (1) clearly indicate which questions need to be completed for a net price estimate, (2) clearly mark requests for contact information as optional, (3) prohibit personally identifiable information from being sold or made available to third parties, and (4) clearly state that any information a user provides is confidential and that the calculator does not store responses or require personal identifying information. Authorizes the Secretary of Education to develop a universal net price calculator that enables users to answer one set of questions and receive net prices for any IHE that is required to have a net price calculator.